Ipsen enters exclusive worldwide tie-up with Accent for its pre-clinical R&D oncology pipeline
Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme
Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme
The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
Equity raise to finance growth and investments in the biological space
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
The consideration for the medicines in India is valued at Rs 180.48 crore
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
Subscribe To Our Newsletter & Stay Updated